193 Hydrocortisone as an intervention (RCT) 6 17. Muris P, Meesters C, van den Berg F. The Strengths and Difficulties Questionnaire (SDQ)--further evidence for its reliability and validity in a community sample of Dutch children and adolescents. Eur Child Adolesc Psychiatry. 2003;12(1):1-8. 18. Bruni O, Ottaviano S, Guidetti V, et al. The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence. J Sleep Res. 1996;5(4):251-261. 19. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000;24(1):38-48. 20. Clement K, van den Akker E, Argente J, et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, openlabel, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020;8(12):960-970. 21. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002;94(7):2090-2106. 22. Haverman L, van Oers HA, Limperg PF, et al. Development and validation of the distress thermometer for parents of a chronically ill child. J Pediatr. 2013;163(4):1140-1146 e1142. 23. CTCAE v5.0: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc. htm#ctc_50. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc. htm#ctc_50. Accessed. 24. Yang L, Panetta JC, Cai X, et al. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol. 2008;26(12):1932-1939. 25. Rensen N, Steur LMH, Schepers SA, et al. Determinants of health-related quality of life proxy rating disagreement between caregivers of children with cancer. Qual Life Res. 2020;29(4):901912. 26. van Hulst AM, Peersmann SHM, van den Akker ELT, et al. Risk factors for steroid-induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review. Psychooncology. 2021;30(7):1009-1028. 27. Colloca L, Finniss D. Nocebo effects, patient-clinician communication, and therapeutic outcomes. JAMA. 2012;307(6):567-568. 28. Kleine-Borgmann J, Bingel U. Nocebo Effects: Neurobiological Mechanisms and Strategies for Prevention and Optimizing Treatment. Int Rev Neurobiol. 2018;138:271-283. 29. Colloca L, Barsky AJ. Placebo and Nocebo Effects. N Engl J Med. 2020;382(6):554-561. 30. Czerniak E, Oberlander TF, Weimer K, Kossowsky J, Enck P. “Placebo by Proxy” and “Nocebo by Proxy” in Children: A Review of Parents’ Role in Treatment Outcomes. Front Psychiatry. 2020;11:169. 31. Mulligan K, Kassoumeri L, Etheridge A, Moncrieffe H, Wedderburn LR, Newman S. Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life. Pediatr Rheumatol Online J. 2013;11(1):23. 32. Bini J, Parikh L, Lacadie C, et al. Stress-level glucocorticoids increase fasting hunger and decrease cerebral blood flow in regions regulating eating. Neuroimage Clin. 2022;36:103202. 33. Grelotti DJ, Kaptchuk TJ. Placebo by proxy. BMJ. 2011;343:d4345. 34. Schedlowski M, Enck P, Rief W, Bingel U. Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice. Pharmacol Rev. 2015;67(3):697730.
RkJQdWJsaXNoZXIy MTk4NDMw